| Dr Aaron Michael Ferda, MD | |
|
235 Stokely Rd, Cynthiana, KY 41031-2104 | |
| (859) 954-5150 | |
| (859) 954-5160 |
| Full Name | Dr Aaron Michael Ferda |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 15 Years |
| Location | 235 Stokely Rd, Cynthiana, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265666218 | NPI | - | NPPES |
| 7100370360 | Medicaid | KY | |
| 0085335 | Medicaid | OH | |
| 3810025978 | Medicaid | WV |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spero Health Of Kentucky, Llc | 1052792041 | 35 |
News Archive
An international public-private research team led by scientists at the Broad Institute of MIT and Harvard announced today the construction and availability of an extensive library of molecular reagents to silence most human and mouse genes.
New legislation in the United States will mean that health insurance companies will have to offer mental health coverage on a par with financial and treatment coverage offered for other physical illnesses such as heart disease, diabetes or asthma.
Dr. Judd Shellito, Chief of the Section of Pulmonary and Critical Care Medicine at LSU Health Sciences Center New Orleans, has been awarded approximately $9 million in grant funding to develop a vaccine against Pneumocystis, an important cause of pneumonia in people with HIV infection. This potentially fatal illness is the most common serious opportunistic infection in people with HIV.
Trevena, Inc., the leader in discovery and development of G-protein coupled receptor (GPCR) biased ligands, announced today the initiation of a Phase I clinical trial of TRV130, a novel candidate designed for the intravenous treatment of moderate-to-severe post-operative pain.
Robyn Wing, M.D., an emergency medicine physician at Hasbro Children's Hospital, recently led a study that found children who were exposed to an adverse childhood experience (ACE) were 28 percent more likely to develop asthma.
› Verified 7 days ago
| Entity Name | My Turning Point Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497247894 PECOS PAC ID: 1759628340 Enrollment ID: O20190118002570 |
News Archive
An international public-private research team led by scientists at the Broad Institute of MIT and Harvard announced today the construction and availability of an extensive library of molecular reagents to silence most human and mouse genes.
New legislation in the United States will mean that health insurance companies will have to offer mental health coverage on a par with financial and treatment coverage offered for other physical illnesses such as heart disease, diabetes or asthma.
Dr. Judd Shellito, Chief of the Section of Pulmonary and Critical Care Medicine at LSU Health Sciences Center New Orleans, has been awarded approximately $9 million in grant funding to develop a vaccine against Pneumocystis, an important cause of pneumonia in people with HIV infection. This potentially fatal illness is the most common serious opportunistic infection in people with HIV.
Trevena, Inc., the leader in discovery and development of G-protein coupled receptor (GPCR) biased ligands, announced today the initiation of a Phase I clinical trial of TRV130, a novel candidate designed for the intravenous treatment of moderate-to-severe post-operative pain.
Robyn Wing, M.D., an emergency medicine physician at Hasbro Children's Hospital, recently led a study that found children who were exposed to an adverse childhood experience (ACE) were 28 percent more likely to develop asthma.
› Verified 7 days ago
| Entity Name | Trending Upwards |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477081206 PECOS PAC ID: 7012258437 Enrollment ID: O20190412001478 |
News Archive
An international public-private research team led by scientists at the Broad Institute of MIT and Harvard announced today the construction and availability of an extensive library of molecular reagents to silence most human and mouse genes.
New legislation in the United States will mean that health insurance companies will have to offer mental health coverage on a par with financial and treatment coverage offered for other physical illnesses such as heart disease, diabetes or asthma.
Dr. Judd Shellito, Chief of the Section of Pulmonary and Critical Care Medicine at LSU Health Sciences Center New Orleans, has been awarded approximately $9 million in grant funding to develop a vaccine against Pneumocystis, an important cause of pneumonia in people with HIV infection. This potentially fatal illness is the most common serious opportunistic infection in people with HIV.
Trevena, Inc., the leader in discovery and development of G-protein coupled receptor (GPCR) biased ligands, announced today the initiation of a Phase I clinical trial of TRV130, a novel candidate designed for the intravenous treatment of moderate-to-severe post-operative pain.
Robyn Wing, M.D., an emergency medicine physician at Hasbro Children's Hospital, recently led a study that found children who were exposed to an adverse childhood experience (ACE) were 28 percent more likely to develop asthma.
› Verified 7 days ago
| Entity Name | Spero Health Of Kentucky, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982102109 PECOS PAC ID: 1052792041 Enrollment ID: O20220721003823 |
News Archive
An international public-private research team led by scientists at the Broad Institute of MIT and Harvard announced today the construction and availability of an extensive library of molecular reagents to silence most human and mouse genes.
New legislation in the United States will mean that health insurance companies will have to offer mental health coverage on a par with financial and treatment coverage offered for other physical illnesses such as heart disease, diabetes or asthma.
Dr. Judd Shellito, Chief of the Section of Pulmonary and Critical Care Medicine at LSU Health Sciences Center New Orleans, has been awarded approximately $9 million in grant funding to develop a vaccine against Pneumocystis, an important cause of pneumonia in people with HIV infection. This potentially fatal illness is the most common serious opportunistic infection in people with HIV.
Trevena, Inc., the leader in discovery and development of G-protein coupled receptor (GPCR) biased ligands, announced today the initiation of a Phase I clinical trial of TRV130, a novel candidate designed for the intravenous treatment of moderate-to-severe post-operative pain.
Robyn Wing, M.D., an emergency medicine physician at Hasbro Children's Hospital, recently led a study that found children who were exposed to an adverse childhood experience (ACE) were 28 percent more likely to develop asthma.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron Michael Ferda, MD 928 Belmere Dr, Lexington, KY 40509-2248 Ph: (859) 618-4762 | Dr Aaron Michael Ferda, MD 235 Stokely Rd, Cynthiana, KY 41031-2104 Ph: (859) 954-5150 |
News Archive
An international public-private research team led by scientists at the Broad Institute of MIT and Harvard announced today the construction and availability of an extensive library of molecular reagents to silence most human and mouse genes.
New legislation in the United States will mean that health insurance companies will have to offer mental health coverage on a par with financial and treatment coverage offered for other physical illnesses such as heart disease, diabetes or asthma.
Dr. Judd Shellito, Chief of the Section of Pulmonary and Critical Care Medicine at LSU Health Sciences Center New Orleans, has been awarded approximately $9 million in grant funding to develop a vaccine against Pneumocystis, an important cause of pneumonia in people with HIV infection. This potentially fatal illness is the most common serious opportunistic infection in people with HIV.
Trevena, Inc., the leader in discovery and development of G-protein coupled receptor (GPCR) biased ligands, announced today the initiation of a Phase I clinical trial of TRV130, a novel candidate designed for the intravenous treatment of moderate-to-severe post-operative pain.
Robyn Wing, M.D., an emergency medicine physician at Hasbro Children's Hospital, recently led a study that found children who were exposed to an adverse childhood experience (ACE) were 28 percent more likely to develop asthma.
› Verified 7 days ago